The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Advances in Copper Complexes as Anticancer Agents
Abstract
Copper is a transition metal that can exist in oxidized (Cu(II)) and reduced (Cu(I)) states. This allows it to participate in redox and catalytic chemistry, making it a suitable cofactor for a diverse range of enzymes and molecules. Copper complexes have been investigated for their therapeutic or diagnostic potential showing effectiveness in cancer treatment due to their cytotoxic action on tumour cells. In this review, the most remarkable achievements in the design and development of copper(I, II) complexes as antitumor agents are discussed. Special emphasis has been focused on the identification of structure-activity relationships for the different classes of complexes. Up to now, despite the enormous efforts in synthesizing different classes of copper complexes, very few data concerning the molecular basis of the mechanisms underlying their antitumor activity are available. The current overview, collecting the most significant strategies adopted in the last four years to design promising anticancer copper(I,II) compounds, aims to provide a useful reference for researchers working in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chatterjee, S., Mookerjee, A., Basu, J. M., Chakraborty, P., Ganguly, A., Adhikary, A., Mukhopadhyay, D., Ganguli, S., Banerjee, R., Ashraf, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007048 · Cited by 46
RetractedMetals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Bourissou, D., Guerret, O., Gabbaï, F. P., & Bertrand, G. (2000) · Chemical Reviews · doi:10.1021/cr940472u · Cited by 3,633
Heterocyclic Carbenes: Synthesis and Coordination Chemistry
Hahn, F. E., & Jahnke, M. C. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703883 · Cited by 2,775
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Herrmann, W. A., & Köcher, C. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199721621 · Cited by 1,687
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Mechanisms for copper acquisition, distribution and regulation
Kim, B.-E., Nevitt, T., & Thiele, D. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.72 · Cited by 1,588
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Copper: An essential metal in biology
Festa, R. A., & Thiele, D. J. (2011) · Current Biology · doi:10.1016/j.cub.2011.09.040 · Cited by 1,186
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
Tripoli, E., Guardia, M. L., Giammanco, S., Majo, D. D., & Giammanco, M. (2007) · Food Chemistry · doi:10.1016/j.foodchem.2006.11.054 · Cited by 1,177
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Trace elements in human physiology and pathology. Copper
Tapiero, H., Townsend, D. M., & Tew, K. D. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00012-x · Cited by 1,007
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
C ERULOPLASMIN M ETABOLISM AND F UNCTION
Hellman, N. E., & Gitlin, J. D. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.012502.114457 · Cited by 933
Sigman, D. S., Mazumder, A., & Perrin, D. M. (1993) · Chemical Reviews · doi:10.1021/cr00022a011 · Cited by 921
Copper-Dioxygen Complexes. Inorganic and Bioinorganic Perspectives
Kitajima, N., & Moro-oka, Y. (1994) · Chemical Reviews · doi:10.1021/cr00027a010 · Cited by 875
Copper Complexes as Anticancer Agents
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009787313837 · Cited by 802
Self-citationCopper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
Self-citationThe Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes
(2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487484 · Cited by 777
Bioinorganic Photochemistry: Frontiers and Mechanisms
Szaciłowski, K., Macyk, W., Drzewiecka-Matuszek, A., Brindell, M., & Stochel, G. (2005) · Chemical Reviews · doi:10.1021/cr030707e · Cited by 725
The biological chemistry of the elements
Exley, C. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90327-6 · Cited by 717
Principles of bioinorganic chemistry
Vella, F. (1995) · Biochemical Education · doi:10.1016/0307-4412(95)90685-1 · Cited by 693
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Linder, M. C. (1991) · Springer eBooks · doi:10.1007/978-1-4757-9432-8 · Cited by 626
Eichhorn, G. L., & Shin, Y. A. (1968) · Journal of the American Chemical Society · doi:10.1021/ja01028a024 · Cited by 597
Hegg, E. L., & Burstyn, J. N. (1998) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00157-x · Cited by 567
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Arredondo, M., & Núñez, M. T. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.010 · Cited by 550
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
The Haber-Weiss cycle – 70 years later
Koppenol, W. H. (2001) · Redox Report · doi:10.1179/135100001101536373 · Cited by 504
So, F. V., Guthrie, N., Chambers, A. F., Moussa, M., & Carroll, K. K. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514473 · Cited by 488
Activation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 481
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
Anderson, C. J., & Welch, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980451q · Cited by 455
Interactions of Metal−Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNA
Chifotides, H. T., & Dunbar, K. R. (2005) · Accounts of Chemical Research · doi:10.1021/ar0302078 · Cited by 445
Comprehensive coordination chemistry II: from biology to nanotechnology
(2004) · Choice Reviews Online · doi:10.5860/choice.41-6540 · Cited by 420
Structural Biology of Copper Trafficking
Boal, A. K., & Rosenzweig, A. C. (2009) · Chemical Reviews · doi:10.1021/cr900104z · Cited by 420
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Yu, Y., Kalinowski, D. S., Kovacevic, Z., Siafakas, A. R., Jansson, P. J., Stefani, C., Lovejoy, D. B., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900552r · Cited by 397
Puig, S., Lee, J., Lau, M., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202547200 · Cited by 396
Peters, J. M., Franke, W. W., & Kleinschmidt, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37345-3 · Cited by 388
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Richardson, D. R., Sharpe, P. C., Lovejoy, D. B., Senaratne, D., Kalinowski, D. S., Islam, M., & Bernhardt, P. V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606342 · Cited by 383
Yuan, J., Lovejoy, D. B., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-03-0868 · Cited by 381
Antioxidant and Chelating Properties of Flavonoids
Korkina, L. G., & Afanas'Ev, I. B. (1996) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60983-7 · Cited by 375
Development of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 369
Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors
Russo, A., Acquaviva, R., Campisi, A., Sorrenti, V., Di Giacomo, C., Virgata, G., Barcellona, M. L., & Vanella, A. (2000) · Cell Biology and Toxicology · doi:10.1023/a:1007685909018 · Cited by 346
Developing new metal-based therapeutics: challenges and opportunities
Hambley, T. W. (2007) · Dalton Transactions · doi:10.1039/b706075k · Cited by 337
Copper and Its Complexes in Medicine: A Biochemical Approach
Iakovidis, I., Delimaris, I., & Piperakis, S. M. (2011) · Molecular Biology International · doi:10.4061/2011/594529 · Cited by 336
Adsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q. P., Padhye, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060712l · Cited by 334
Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1322 · Cited by 326
Tardito, S., Bassanetti, I., Bignardi, C., Elviri, L., Tegoni, M., Mucchino, C., Bussolati, O., Franchi-Gazzola, R., & Marchiò, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja109413c · Cited by 322
Brewer, G. J., Dick, R. D., Grover, D. K., LeClaire, V., Tseng, M., Wicha, M. S., Pienta, K. J., Redman, B. G., Jahan, T. M., Sondak, V. K., et al. (2000) · PubMed · Cited by 319
Lovejoy, D. B., Jansson, P. J., Brunk, U. T., Wong, J., Ponka, P., & Richardson, D. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1218 · Cited by 308
Concepts and models in bioinorganic chemistry
(2007) · Choice Reviews Online · doi:10.5860/choice.44-5065 · Cited by 305
Selvakumar, B., Rajendiran, V., Uma Maheswari, P., Stoeckli-Evans, H., & Palaniandavar, M. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.11.018 · Cited by 303
Functions of the Proteasome: the Lysis at the End of the Tunnel
Goldberg, A. L. (1995) · Science · doi:10.1126/science.7725095 · Cited by 300
Paterson, B. M., & Donnelly, P. S. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00215a · Cited by 299
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
Thompson, K. H., & Orvig, C. (2006) · Dalton Trans. · doi:10.1039/b513476e · Cited by 298
Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals
Wadas, T., Wong, E., Weisman, G., & Anderson, C. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207779313768 · Cited by 296
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Zutphen, S. V., & Reedijk, J. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.03.005 · Cited by 295
Copper complexes as therapeutic agents
Duncan, C., & White, A. R. (2012) · Metallomics · doi:10.1039/c2mt00174h · Cited by 294
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Ishida, S., McCormick, F., Smith-McCune, K., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.011 · Cited by 288
Arnesano, F., & Natile, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.028 · Cited by 282
Bhat, S. S., Kumbhar, A. A., Heptullah, H., Khan, A. A., Gobre, V. V., Gejji, S. P., & Puranik, V. G. (2011) · Inorganic Chemistry · doi:10.1021/ic101534n · Cited by 268
Linder, M., Wooten, L., Cerveza, P., Cotton, S., Shulze, R., & Lomeli, N. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.965s · Cited by 267
Ramakrishnan, S., Rajendiran, V., Palaniandavar, M., Periasamy, V. S., Srinag, B. S., Krishnamurthy, H., & Akbarsha, M. A. (2009) · Inorganic Chemistry · doi:10.1021/ic801144x · Cited by 264
Copper Compounds in Anticancer Strategies
Tardito, S., & Marchio, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787846532 · Cited by 255
Mechanism of the Fenton reaction. Evidence for a new intermediate
Kremer, M. L. (1999) · Physical Chemistry Chemical Physics · doi:10.1039/a903915e · Cited by 255
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., & Marnett, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.925 · Cited by 252
Copper-related diseases: From chemistry to molecular pathology
Crisponi, G., Nurchi, V. M., Fanni, D., Gerosa, C., Nemolato, S., & Faa, G. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.12.018 · Cited by 249
Jansson, P. J., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100561b · Cited by 243
Copper in Medicine: Homeostasis, Chelation Therapy and Antitumor Drug Design
Wang, T., & Guo, Z. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055742 · Cited by 233
Qiao, X., Ma, Z.-Y., Xie, C.-Z., Xue, F., Zhang, Y.-W., Xu, J.-Y., Qiang, Z.-Y., Lou, J.-S., Chen, G.-J., & Yan, S.-P. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.01.004 · Cited by 233
Maheswari, P. U., Roy, S., den Dulk, H., Barends, S., van Wezel, G., Kozlevčar, B., Gamez, P., & Reedijk, J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056970+ · Cited by 231
Molecular imaging with copper-64
Smith, S. V. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.06.009 · Cited by 230
Fox, S. B., Gasparini, G., & Harris, A. L. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00323-5 · Cited by 230
Role of Copper in Angiogenesis and Its Medicinal Implications
Xie, H., & Kang, Y. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787846622 · Cited by 229
Luis García-Giménez, J., González-Álvarez, M., Liu-González, M., Macías, B., Borrás, J., & Alzuet, G. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.04.003 · Cited by 227
Structure and function of “metalloantibiotics”
Ming, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10052 · Cited by 227
Bravo-Gómez, M. E., García-Ramos, J. C., Gracia-Mora, I., & Ruiz-Azuara, L. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.10.006 · Cited by 223
Campbell, N. H., Karim, N. H. A., Parkinson, G. N., Gunaratnam, M., Petrucci, V., Todd, A. K., Vilar, R., & Neidle, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201140v · Cited by 220
Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study
Geraki, K., Farquharson, M. J., & Bradley, D. A. (2002) · Physics in Medicine and Biology · doi:10.1088/0031-9155/47/13/310 · Cited by 214
Chen, D., Cui, Q. C., Yang, H., Barrea, R. A., Sarkar, F. H., Sheng, S., Yan, B., Reddy, G. P. V., & Dou, Q. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3546 · Cited by 212
Cvek, B., Milacic, V., Taraba, J., & Dou, Q. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007807 · Cited by 209
Senthil Raja, D., Bhuvanesh, N. S. P., & Natarajan, K. (2011) · Inorganic Chemistry · doi:10.1021/ic2020308 · Cited by 206
Thiosemicarbazones: The New Wave in Cancer Treatment
Kalinowski, D. S., Quach, P., & Richardson, D. R. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.80 · Cited by 198
Huang, H., Chen, Q., Ku, X., Meng, L., Lin, L., Wang, X., Zhu, C., Wang, Y., Chen, Z., Li, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9014394 · Cited by 197
Senthil Raja, D., Bhuvanesh, N. S. P., & Natarajan, K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.038 · Cited by 195
Chelators at the cancer coalface: Desferrioxamine to Triapine and beyond
Yu, Y., Wong, J., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1954 · Cited by 195
Pereira, R. M., Andrades, N. E., Paulino, N., Sawaya, A. C., Eberlin, M. N., Marcucci, M. C., Favero, G. M., Novak, E. M., & Bydlowski, S. P. (2007) · Molecules · doi:10.3390/12071352 · Cited by 193
Berners-Price, S. J., & Sadler, P. J. (1988) · Structure and Bonding · doi:10.1007/3-540-50130-4_2 · Cited by 184
Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors
Yoshida, D., Ikeda, Y., & Nakazawa, S. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01324697 · Cited by 182
Copper intake and assessment of copper status
Milne, D. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.1041s · Cited by 182
Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease
Brewer, G. J. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600712 · Cited by 179
Raja, D. S., Ganesan, P., Bhuvanesh, N. S. P., Reibenspies, J. H., Renganathan, R., & Natarajan, K. (2011) · Dalton Transactions · doi:10.1039/c0dt01657h · Cited by 177
Barve, A., Kumbhar, A., Bhat, M., Joshi, B., Butcher, R., Sonawane, U., & Joshi, R. (2009) · Inorganic Chemistry · doi:10.1021/ic9004642 · Cited by 172
Yoshii, J., Yoshiji, H., Kuriyama, S., Ikenaka, Y., Noguchi, R., Okuda, H., Tsujinoue, H., Nakatani, T., Kishida, H., Nakae, D., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1537 · Cited by 170
O’Connor, M., Kellett, A., McCann, M., Rosair, G., McNamara, M., Howe, O., Creaven, B. S., McClean, S., Foltyn-Arfa Kia, A., O’Shea, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201041d · Cited by 170
Lovejoy, D. B., & Richardson, D. R. (2002) · Blood · doi:10.1182/blood.v100.2.666 · Cited by 168
Copper deficiency as an anti-cancer strategy.
Goodman, V. L., Brewer, G. J., & Merajver, S. D. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110255 · Cited by 168
Krishnamoorthy, P., Sathyadevi, P., Butorac, R. R., Cowley, A. H., Bhuvanesh, N. S. P., & Dharmaraj, N. (2012) · Dalton Transactions · doi:10.1039/c2dt11938b · Cited by 167
El-Sherif, A. A., & Eldebss, T. M. A. (2011) · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2011.05.062 · Cited by 166
Katsarou, M. E., Efthimiadou, E. K., Psomas, G., Karaliota, A., & Vourloumis, D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7013259 · Cited by 162
Serum and Tissue Trace Metal Levels in Lung Cancer
Díez, M., Arroyo, M., Cerdàn, F. J., Muñoz, M., Martin, M. A., & Balibrea, J. L. (1989) · Oncology · doi:10.1159/000226722 · Cited by 161
Kagawa, T. F., Geierstanger, B. H., Wang, A. H., & Ho, P. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54906-1 · Cited by 161
Copper-dependent cleavage of DNA by bleomycin
Ehrenfeld, G. M., Shipley, J. B., Heimbrook, D. C., Sugiyama, H., Long, E. C., BOOM, J. H. V., van der MAREL, G. A., Oppenheimer, N. J., & Hecht, S. M. (1987) · Biochemistry · doi:10.1021/bi00377a038 · Cited by 156
Rao, V. A., Klein, S. R., Agama, K., Toyoda, E., Adachi, N., Pommier, Y. G., & Shacter, E. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1437 · Cited by 156
Genotoxicity of the copper antineoplastic coordination complexes casiopeinas®
Serment-Guerrero, J. H., Cano‐Sánchez, P., Reyes-Perez, E., Velazquez-Garcia, F., Gómez, M. E. B., & Ruíz-Azuara, L. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.05.008 · Cited by 155
Gandin, V., Pellei, M., Tisato, F., Porchia, M., Santini, C., & Marzano, C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01292.x · Cited by 154
Self-citationROS-activated Anticancer Prodrugs: a New Strategy for tumor-specific Damage
Peng, X., & Gandhi, V. V. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.61 · Cited by 151
Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells
Chiang, L., Ng, L., Lin, I.-C., Kuo, P., & Lin, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.002 · Cited by 150
Hegg, E. L., & Burstyn, J. N. (1996) · Inorganic Chemistry · doi:10.1021/ic960384n · Cited by 147
Devereux, M. M., O′Shea, D., O’Connor, M. J., Grehan, H., Connor, G., McCann, M., Rosair, G. M., Lyng, F. M., Kellett, A., Walsh, M., et al. (2007) · Polyhedron · doi:10.1016/j.poly.2007.05.006 · Cited by 145
Goswami, T. K., Chakravarthi, B. V. S. K., Roy, M., Karande, A. A., & Chakravarty, A. R. (2011) · Inorganic Chemistry · doi:10.1021/ic201028e · Cited by 142
Tumour vasculature as a target for anticancer therapy
Eatock, M. M., Schätzlein, A. G., & Kaye, S. B. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0158 · Cited by 139
Milacic, V., Chen, D., Giovagnini, L., Diez, A., Fregona, D., & Dou, Q. P. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.009 · Cited by 139
Specific binding of angiogenin to calf pulmonary artery endothelial cells.
Badet, J., Soncin, F., Guitton, J., Lamare, O., Cartwright, T., & Barritault, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8427 · Cited by 137
Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales
Kirk, K. L. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777951073 · Cited by 136
Trejo‐Solís, C., Jiménez‐Farfán, D., Rodríguez‐Enríquez, S., Fernández‐Valverde, F., Cruz-Salgado, A., Ruíz-Azuara, L., & Sotelo, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-156 · Cited by 136
Galal, S. A., Hegab, K. H., Kassab, A. S., Rodriguez, M. L., Kerwin, S. M., EL‐KHAMRY, A. A., & Diwani, H. I. E. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.07.013 · Cited by 135
Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi
Júnior, E. N. D. S., Menna‐Barreto, R. F. S., Pinto, M. D. C. F. R., Silva, R. S. F., Teixeira, D. V., de Souza, M. C. B. V., de Simone, C. A., de Castro, S. L., Ferreira, V. F., & Pinto, A. V. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.10.015 · Cited by 135
Serum trace elements and Cu/Zn ratio in breast cancer patients
Gupta, S., Shukla, V. K., Vaidya, M. P., Roy, S. K., & Gupta, S. (1991) · Journal of Surgical Oncology · doi:10.1002/jso.2930460311 · Cited by 133
Anticopper therapy against cancer and diseases of inflammation and fibrosis
Brewer, G. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03541-5 · Cited by 131
Ferrari, M. B., Bisceglie, F., Pelosi, G., Tarasconi, P., Albertini, R., Dall'Aglio, P. P., Pinelli, S., Bergamo, A., & Sava, G. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2003.09.011 · Cited by 130
Tardito, S., Isella, C., Médico, E., Marchiò, L., Bevilacqua, E., Hatzoglou, M., Bussolati, O., & Franchi‐Gazzola, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026583 · Cited by 130
Chen, G.-J., Qiao, X., Qiao, P.-Q., Xu, G.-J., Xu, J., Tian, J., Gu, W., Liu, X., & Yan, S. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.11.008 · Cited by 129
Yeh, C., Wang, J., Cheng, T., Juan, C.-H., Wu, C.-H., & Lin, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.050 · Cited by 128
Tan, J., Wang, B., & Zhu, L. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0486-8 · Cited by 124
Trejo‐Solís, C., Palencia, G., Zuñiga, S., Rodríguez-Ropón, A., Osorio‐Rico, L., Sánchez‐Torres, L. E., Gracia‐Mora, I., Márquez‐Rosado, L., Sánchez, A., Moreno‐García, M. E., et al. (2005) · Neoplasia · doi:10.1593/neo.04607 · Cited by 123
Hancock, C. N., Stockwin, L. H., Han, B., Divelbiss, R. D., Jun, J. H., Malhotra, S. V., Hollingshead, M. G., & Newton, D. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.696 · Cited by 120
Feun, L. G., Modiano, M., Lee, K. C., Mao, J., Marini, A., Savaraj, N., Plezia, P. M., Almassian, B., Colacino, E., Fischer, J., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0480-0 · Cited by 120
Pipes and wiring: the regulation of copper uptake and distribution in yeast
Labbé, S., & Thiele, D. J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01638-8 · Cited by 120
Maity, B., Roy, M., Banik, B., Majumdar, R., Dighe, R. R., & Chakravarty, A. R. (2010) · Organometallics · doi:10.1021/om100524x · Cited by 117
(2011) · Wiley eBooks · doi:10.1002/9781118094365 · Cited by 117
Rivero‐Müller, A., Vizcaya‐Ruíz, A. D., Plant, N. J., Ruiz, L., & Dobrota, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.002 · Cited by 115
Ghosh, K. S., Sahoo, B. K., Jana, D., & Dasgupta, S. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.04.008 · Cited by 114
Carvallo, F. R., Trejo‐Solís, C., Gómez-Ruíz, C., Rodríguez-Aguilera, E., Macías‐Rosales, L., Barberena, E. C., Cedillo-Peláez, C., Gracia‐Mora, I., Ruíz-Azuara, L., Madrid‐Marina, V., et al. (2007) · BioMetals · doi:10.1007/s10534-007-9089-4 · Cited by 113
Chakraborty, A., Kumar, P., Ghosh, K., & Roy, P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.003 · Cited by 109
Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity
Creaven, B. S., Devereux, M. M., Karcz, D., et al. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.05.017 · Cited by 109
Sathyadevi, P., Krishnamoorthy, P., Butorac, R. R., Cowley, A. H., & Dharmaraj, N. (2012) · Metallomics · doi:10.1039/c2mt00004k · Cited by 109
Lönnerdal, B. L. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.821 · Cited by 108
Chen, D., Frezza, M., Shakya, R., Cui, Q. C., Milacic, V., Verani, C. N., & Dou, Q. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1813 · Cited by 108
Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasome
Hindo, S. S., Frezza, M., Tomco, D., Heeg, M. J., Hryhorczuk, L. M., McGarvey, B. R., Dou, Q. P., & Verani, C. N. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.05.019 · Cited by 108
Kumar, R. S., & Arunachalam, S. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.11.001 · Cited by 108
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
Wang, F., Jiao, P., Qi, M., Frezza, M., Dou, Q. P., & Yan, B. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859315 · Cited by 107
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)
Alemón‐Medina, R., Breña-Valle, M., Muñoz-Sánchez, J. L., Gracia‐Mora, I., & Ruíz-Azuara, L. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0364-9 · Cited by 107
Thati, B., Noble, A., Rowan, R., Creaven, B. S., Walsh, M., McCann, M., Egan, D. A., & Kavanagh, K. A. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.01.022 · Cited by 107
Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
Lowndes, S. A., Adams, A., Timms, A., Fisher, N., Smythe, J., Watt, S. M., Joel, S., Doñate, F., Hayward, C., Reich, S. D., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0315 · Cited by 107
Suntharalingam, K., White, A. J. P., & Vilar, R. (2010) · Inorganic Chemistry · doi:10.1021/ic100884p · Cited by 104
XIAP: Cell death regulation meets copper homeostasis
Mufti, A., Burstein, E., & Duckett, C. S. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.033 · Cited by 104
Qin, Y., Meng, L., Hu, C., Duan, W., Zuo, Z., Lin, L., Zhang, X., & Ding, J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0147 · Cited by 101
Roşu, T., Pahonțu, E., Păsculescu, S., Georgescu, R., Stănică, N., Curaj, A., Popescu, A., & Leabu, M. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.12.015 · Cited by 98
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.025 · Cited by 96
The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones.
Miller, M. C., Stineman, C. N., Vance, J. R., West, D. X., & Hall, I. H. (1999) · PubMed · Cited by 96
Raja, D. S., Bhuvanesh, N. S. P., & Natarajan, K. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0844-1 · Cited by 92
Rajalakshmi, S., Weyhermüller, T., Freddy, A. J., Vasanthi, H. R., & Nair, B. U. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.041 · Cited by 91
A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
Pass, H. I., Brewer, G. J., Dick, R., Carbone, M., & Merajver, S. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.03.016 · Cited by 90
Suntharalingam, K., Hunt, D. J., Duarte, A. A., White, A. J. P., Mann, D. J., & Vilar, R. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202482 · Cited by 89
Li, D., Tian, J., Gu, W., Liu, X., Zeng, H.-H., & Yan, S. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.03.012 · Cited by 87
Kellett, A., Howe, O. L., O’Connor, M. J., McCann, M., Creaven, B. S., McClean, S., Kia, A. F.-A., Casey, A., & Devereux, M. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.034 · Cited by 85
Robertazzi, A., Vargiu, A. V., Magistrato, A., Ruggerone, P., Carloni, P., de Hoog, P., & Reedijk, J. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp901210g · Cited by 85
Fleming, A. M., Muller, J. G., Ji, I., & Burrows, C. J. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05112a · Cited by 84
Hassouneh, B., Islam, M., Nagel, T., Pan, Q., Merajver, S. D., & Teknos, T. N. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0524 · Cited by 83
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm
Khan, G. N., & Merajver, S. D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902845622 · Cited by 80
Tardito, S., Bussolati, O., Maffini, M., Tegoni, M., Giannetto, M., Dall’Asta, V., Franchi‐Gazzola, R., Lanfranchi, M., Pellinghelli, M. A., Mucchino, C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061174f · Cited by 80
ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complex
Guo, W.-J., Ye, S.-S., Cao, N., Huang, J., Gao, J., & Chen, Q. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.08.001 · Cited by 79
Rajalakshmi, S., Weyhermüller, T., Dinesh, M. G., & Nair, B. U. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.08.010 · Cited by 79
Anbu, S., Kandaswamy, M., Kamalraj, S., Muthumary, J., & Varghese, B. (2011) · Dalton Transactions · doi:10.1039/c1dt10277j · Cited by 77
Claassen, G. F., Brin, E., Crogan‐Grundy, C., Vaillancourt, M. T., Zhang, H. Z., Cai, S. X., Drewe, J. A., Tseng, B., & Kasibhatla, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.032 · Cited by 77
Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry
Chen, Z., Tan, M., Liu, L., Liu, Y., Wang, H., Yang, B., Peng, Y., Liu, H., Liang, H., & Orvig, C. (2009) · Dalton Transactions · doi:10.1039/b910133k · Cited by 76
Balzarini, J. M., Keyaerts, E., Vijgen, L., van der Meer, F. J. U. M., Stevens, M., Clercq, E. D., Egberink, H. F., & Ranst, M. A. V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki481 · Cited by 76
Zhang, Z., Bi, C., Schmitt, S. M., Fan, Y., Dong, L., Zuo, J., & Dou, Q. P. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0940-x · Cited by 76
Balakrishna, M. S., Suresh, D., Rai, A., Mague, J. T., & Panda, D. (2010) · Inorganic Chemistry · doi:10.1021/ic100944d · Cited by 74
Anaerobic Photocleavage of DNA in Red Light by Dicopper(II) Complexes of 3,3′-Dithiodipropionic Acid
Lahiri, D., Bhowmick, T., Pathak, B., Shameema, O., Patra, A. K., Ramakumar, S., & Chakravarty, A. R. (2008) · Inorganic Chemistry · doi:10.1021/ic800806j · Cited by 74
The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: An EPR study
Jansson, P. J., Hawkins, C. L., Lovejoy, D. B., & Richardson, D. R. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.07.012 · Cited by 72
Systems biology approach to Wilson’s disease
Burkhead, J. L., Gray, L. W., & Lutsenko, S. (2011) · BioMetals · doi:10.1007/s10534-011-9430-9 · Cited by 70
Buchtík, R., Trávníček, Z., & Vančo, J. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.07.009 · Cited by 69
Buchtík, R., Trávnı́ček, Z., Vančo, J., Herchel, R., & Dvořák, Z. (2011) · Dalton Transactions · doi:10.1039/c1dt10674k · Cited by 68
Raman, N., Jeyamurugan, R., Senthilkumar, R., Balasubramanian, R., & Franzblau, S. G. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.004 · Cited by 66
Guin, P. S., Das, S. K., & Mandal, P. C. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.09.020 · Cited by 66
Maity, B., Gadadhar, S., Goswami, T. K., Karande, A. A., & Chakravarty, A. R. (2011) · Dalton Transactions · doi:10.1039/c1dt11102g · Cited by 64
Sensor/Effector Drug Design with Potential Relevance to Cancer
Fry, F. H., & Jacob, C. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010512 · Cited by 61
Pang, H., Chen, D., Cui, Q. C., & Dou, Q. P. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.809 · Cited by 61
Non-apoptotic programmed cell death induced by a copper(II) complex in human fibrosarcoma cells
Tardito, S., Bussolati, O., Gaccioli, F., Gatti, R., Guizzardi, S., Uggeri, J., Marchiò, L., Lanfranchi, M., & Franchi‐Gazzola, R. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0183-4 · Cited by 60
West, D. X., Carlson, C. S., Galloway, C. P., et al. (1990) · Transition Metal Chemistry · doi:10.1007/bf01023893 · Cited by 60
Wenzel, U., Nickel, A. G., & Daniel, H. (2005) · Journal of Nutrition · doi:10.1093/jn/135.6.1510 · Cited by 59
New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents
Urquiola, C., Gambino, D., Cabrera, M., Lavaggi, M. L., Cerecetto, H., González, M., de Ceráin, A. L., Monge, A., Costa-Filho, A. J., & Torre, M. H. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.07.028 · Cited by 58
Potent oxidative DNA cleavage by the di-copper cytotoxin: [Cu2(μ-terephthalate)(1,10-phen)4]2+
Prisecaru, A., Devereux, M. M., Barron, N., McCann, M., Colleran, J. J., Casey, A., McKee, V., & Kellett, A. (2012) · Chemical Communications · doi:10.1039/c2cc31023f · Cited by 57
Pyrophosphate-bridged complexes with picomolar toxicity
Ikotun, O. F., Higbee-Dempsey, E. M., Ouellette, W., & Doyle, R. P. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.07.010 · Cited by 57
Syntheses, characterization and antitumor activities of transition metal complexes with isoflavone
Chen, X., Tang, L., Sun, Y., Qiu, P., & Liang, G. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.11.008 · Cited by 56
Roy, S., Saha, S., Majumdar, R., Dighe, R. R., & Chakravarty, A. R. (2010) · Polyhedron · doi:10.1016/j.poly.2010.06.028 · Cited by 55
Kumar, R. S., Arunachalam, S., Periasamy, V. S., Preethy, C. P., Riyasdeen, A., & Akbarsha, M. A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.09.017 · Cited by 55
Hernández‐Esquivel, L., Marín‐Hernández, Á., Pavón, N., Carvajal, K., & Moreno‐Sánchez, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.06.023 · Cited by 55
Krishna, P. M., Reddy, K. H., Pandey, J. P., & Siddavattam, D. (2008) · Transition Metal Chemistry · doi:10.1007/s11243-008-9094-7 · Cited by 54
Giovagnini, L., Sitran, S., Montopoli, M., Caparrotta, L., Corsini, M., Rosani, C., Zanello, P., Dou, Q. P., & Fregona, D. (2008) · Inorganic Chemistry · doi:10.1021/ic800404e · Cited by 51
Roy, S., Maheswari, P. U., Lutz, M., Spek, A. L., den Dulk, H., Barends, S., van Wezel, G. P., Hartl, F., & Reedijk, J. (2009) · Dalton Transactions · doi:10.1039/b911542k · Cited by 51
Jia, L., Jiang, P., Xu, J., Hao, Z.-Y., Xu, X., Chen, L., Wu, J., Tang, N., Wang, Q. L., & Vittal, J. J. (2010) · Inorganica Chimica Acta · doi:10.1016/j.ica.2009.12.047 · Cited by 49
Cited by
Connecting copper and cancer: from transition metal signalling to metalloplasia
Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S., et al. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,298
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Targeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Dharmaraja, A. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01243 · Cited by 582
Metadata
- Authors
- Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-10-08
- Volume
- 114
- Issue
- 1
- Pages
- 815-862
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W1984883623
- Cited by
- 1,790
- References
- 250
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.